Akeso Biomedical: Funding, Investors & Team (Sep 2026)
Akeso Biomedical is an early-stage company focused on developing new solutions for the treatment of bacterial infections, microbial biofilms, and chronic wounds. The Company is developing products to treat these conditions using a new class of compounds, known as Fe3C, that have broad-spectrum activity against a wide range of bacteria, and a silk biomaterial technology exclusively licensed from Tufts University. It was founded in 2014 and headquartered in Waltham, Massachusetts.
Akeso Biomedical has raised $600k across 1 funding round on record, the most recent an undisclosed round of $600k announced in Feb 2021.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Akeso Biomedical Company Profile and Key Stats
Latest funding round on record: Feb 2021.
Akeso Biomedical Funding Rounds
Akeso Biomedical Founders and Leadership Team
Contact details for the Akeso Biomedical team: 1 of 1 has an email address on file.
Start 14-day free trial →Akeso Biomedical Funding Compared to Other Biotechnology Startups
Akeso Biomedical's latest round of $600k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Akeso Biomedical in Biotechnology and Waltham
Companies Similar to Akeso Biomedical
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Akeso Biomedical Funding FAQs
What does Akeso Biomedical do?
Akeso Biomedical is an early-stage company focused on developing new solutions for the treatment of bacterial infections, microbial biofilms, and chronic wounds. The Company is developing products to treat these conditions using a new class of compounds, known as Fe3C, that have broad-spectrum activity against a wide range of bacteria, and a silk biomaterial technology exclusively licensed from Tufts University. It was founded in 2014 and headquartered in Waltham, Massachusetts.
How much funding has Akeso Biomedical raised?
Akeso Biomedical has raised $600k across 1 round on record. The most recent is an undisclosed round of $600k announced in Feb 2021.
When did Akeso Biomedical last raise funding?
Akeso Biomedical's most recent funding round on record is an undisclosed round of $600k, announced in Feb 2021.
Who is the CEO of Akeso Biomedical?
Simon Williams is listed as CEO at Akeso Biomedical.
Where is Akeso Biomedical headquartered?
Akeso Biomedical is based in Waltham, Massachusetts, United States.
How many employees does Akeso Biomedical have?
Akeso Biomedical is in the 1-10 employee band.
How does Akeso Biomedical's funding compare to other Biotechnology startups?
Akeso Biomedical's latest round of $600k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Akeso Biomedical Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Akeso Biomedical is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.